Co-Diagnostics, Inc. (CODX)
3.71
+1.32
(+55.23%)
USD |
NASDAQ |
May 21, 16:00
3.63
-0.08
(-2.16%)
After-Hours: 06:04
Co-Diagnostics EPS Diluted (Quarterly) : -4.056 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AngioDynamics, Inc. | -0.1944 |
| PAVmed, Inc. | -4.421 |
| Silvergate Capital Corp. | -- |
| Abbott Laboratories | 0.6165 |
| Acme United Corp. | 0.237 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.14M |
| Revenue (Quarterly) | 0.146M |
| Total Expenses (Quarterly) | 9.286M |
| Enterprise Value | 1.572M |
| Gross Profit Margin (Quarterly) | -207.7% |
| Profit Margin (Quarterly) | -6.26K% |
| Earnings Yield | -755.0% |
| Normalized Earnings Yield | -584.94 |